Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Trading Down 79.0 %

Ampio Pharmaceuticals stock opened at $0.00 on Tuesday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $2.47. The company has a market cap of $2,394.00, a PE ratio of 0.00 and a beta of 3.66. The company’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.